DBD · Diebold Nixdorf, Inc - Financials

Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.

Price · DBD

1Y Max

Annual Quarterly

Income Statement

Line item	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Revenue	$3.81B	$3.75B	$97.20M◇	$3.46B	$3.91B	$3.90B
Cost of Revenue	$2.84B	$2.83B	-	$2.70B	$2.86B	$2.87B
Gross Profit	$961.20M	$920.00M	$85.50M◇	$757.30M	$1.04B	$1.03B
R&D	$86.70M	$93.60M	$10.50M◇	$120.70M	$126.30M	$133.40M
SG&A	$632.50M	$643.60M	$73.90M◇	$741.60M	$775.60M	$858.60M
Total Operating Expenses	$719.20M	$737.90M	$85.00M◇	$969.00M	$906.30M	$1.01B
D&A	$127.50M	$40.10M	$56.40M	$29.80M	$46.40M	$73.70M
Operating Income	$242.00M	$182.10M	$500.0K◇	($211.70M)	$137.10M	$24.00M
Interest Expense	$76.80M	$141.30M	-	$199.20M	$195.30M	$292.70M
Income Tax	$24.10M	$64.30M	$245.30M◇	$149.20M	$27.70M	($1.00M)
Net Income	$94.60M	($16.50M)	$2.15B◇	($581.40M)	($78.80M)	($269.10M)
EPS - Basic	$2.57	($0.44)	($1.01)	($7.36)◇	($1.01)◇	-
EPS - Diluted	$2.54	($0.44)	$26.42◇	($3.47)	($1.01)◇	-

Balance Sheet

Line item	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Cash & Equivalents	$368.90M	$296.20M	$550.20M	$319.10M	$388.90M	$324.50M
Accounts Receivable	$609.40M	$588.50M	$721.80M	$612.20M	$595.20M	$646.90M
Inventory	$521.00M	$528.10M	$589.80M	$588.10M	$544.20M	$498.20M
Accounts Payable	$431.10M	$460.20M	$529.00M	$611.60M	$706.30M	$499.90M
Current Assets	$1.79B	$1.67B	$2.15B	$1.77B	$1.89B	$1.86B
Total Assets	$3.85B	$3.54B	$4.16B	$3.06B	$3.51B	$3.66B
Current Liabilities	$1.37B	$1.27B	$1.42B	$1.60B	$1.75B	$1.65B
Long-term Debt	$938.50M	$966.00M	$1.25B	-	-	-
Total Liabilities	$2.75B	$2.61B	$3.08B	$4.44B◇	-	-
Stockholders' Equity	$1.10B	$929.80M	$1.06B	($1.38B)	($845.10M)	($827.10M)
Retained Earnings	$91.90M	($1.10M)	$17.10M	($1.41B)	($822.40M)	($742.30M)

Cash Flow

Line item	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Operating Cash Flow	$300.70M	$149.20M	-	($387.90M)	$123.30M	$18.00M
Investing Cash Flow	($97.60M)	($45.50M)	-	($23.80M)	($49.20M)	($82.60M)
Financing Cash Flow	($143.90M)	($366.50M)	-	$349.80M	($3.60M)	$16.90M
CapEx	-	-	-	-	-	-
Free Cash Flow	-	-	-	-	-	-

Ratios

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Profitability
Gross margin	25.3%	24.5%	88.0%	21.9%	26.7%	26.5%
Operating margin	6.4%	4.9%	0.5%	-6.1%	3.5%	0.6%
EBITDA margin	9.7%	5.9%	58.5%	-5.3%	4.7%	2.5%
Net margin	2.5%	-0.4%	2212.9%	-16.8%	-2.0%	-6.9%
Free cash flow margin	-	-	-	-	-	-
FCF / Net income	-	-	-	-	-	-
R&D / Revenue	2.3%	2.5%	10.8%	3.5%	3.2%	3.4%
SG&A / Revenue	16.6%	17.2%	76.0%	21.4%	19.9%	22.0%
Effective tax rate	20.3%	134.5%	10.2%	-	-	-
Return on assets	2.5%	-0.5%	51.7%	-19.0%	-2.2%	-7.4%
Return on equity	8.6%	-1.8%	202.2%	42.1%	9.3%	32.5%
Return on invested capital	9.5%	4.8%	0.0%	-	-	-
Liquidity
Current ratio	1.30	1.32	1.52	1.10	1.08	1.13
Quick ratio	0.92	0.90	1.10	0.74	0.77	0.82
Cash ratio	0.27	0.23	0.39	0.20	0.22	0.20
Leverage
Debt / Equity	0.85	1.04	1.18	-	-	-
Debt / Assets	0.24	0.27	0.30	-	-	-
Debt / EBITDA	2.54	4.35	22.04	-	-	-
Interest coverage	3.2x	1.3x	-	-1.1x	0.7x	0.1x
Equity multiplier	3.50	3.81	3.91	-2.22	-4.15	-4.42
Liabilities / Assets	0.71	0.74	0.74	1.45	-	-
Efficiency
Asset turnover	0.99	1.06	0.02	1.13	1.11	1.07
Inventory turnover	5.46	5.36	-	4.60	5.26	5.76
Days sales outstanding	58d	57d	2710d	65d	56d	61d
Days inventory outstanding	67d	68d	-	79d	69d	63d
Days payable outstanding	55d	59d	-	83d	90d	64d
Cash conversion cycle	70d	66d	-	61d	35d	60d
Valuation
P / E	26.7x	-	1.1x	-	-	-
P / B	2.3x	1.7x	2.2x	-	-	-
P / S	0.7x	0.4x	24.2x	-	-	-
EV / EBITDA	8.4x	10.3x	53.8x	-	-	-
Growth
Revenue growth (YoY)	1.5%	3759.2%	-97.2%	-11.4%	0.1%	-11.5%
Revenue CAGR (3y)	3.2%	-1.3%	-70.8%	-7.8%	5.6%	-5.4%
Revenue CAGR (5y)	-0.5%	-3.2%	-50.6%	-5.6%	3.3%	10.0%
Gross profit growth (YoY)	4.5%	976.0%	-88.7%	-27.4%	0.8%	-3.0%
Operating income growth (YoY)	32.9%	36320.0%	-	-	471.3%	-
Net income growth (YoY)	-	-	-	-637.8%	70.7%	21.2%
EPS growth (YoY)	-	-	-	-243.6%	-	-
EPS CAGR (3y)	-	-	-	-	-	-
EPS CAGR (5y)	-	-	-	-	-	-
FCF growth (YoY)	-	-	-	-	-	-
FCF CAGR (5y)	-	-	-	-	-	-
Book value growth (YoY)	18.3%	-12.6%	-	-63.4%	-2.2%	-56.0%

Sales by segment

From XBRL dimensional facts in the 10-K period ending 2025-12-31.

Business segments

$3.81B total

Banking Segment$2.80B · 73.5%

Retail Segment$1.01B · 26.5%

Product / service

$3.81B total

Service$2.17B · 57.0%

Product$1.64B · 43.0%

Geographic

$7.32B total

EMEA$2.05B · 28.0%

Americas$1.46B · 20.0%

Europe$1.33B · 18.1%

US$902.30M · 12.3%

DE$724.40M · 9.9%

Other Americas$558.30M · 7.6%

Asia Pacific$293.60M · 4.0%

Stability scores

Altman Z′

FY 2025 · bankruptcy risk

1.45

Grey zone

Private-firm variant - uses book equity instead of market cap. > 2.90 safe · 1.23-2.90 grey · < 1.23 distress.

Piotroski F-score

FY 2025 · 9-point quality

7/9

Strong

✓Net income positive
✓Operating cash flow positive
✓ROA improved YoY
✓Cash flow > net income
✓Long-term debt decreased
✗Current ratio improved
✓No share dilution
✓Gross margin improved
✗Asset turnover improved

Peer comparison

Same SIC group: Calculating & Accounting Machines (No Electronic Computers)

Company	Revenue (last FY)	Net margin	ROE
VYX	$2.69B	2.3%	6.5%
NATL	$4.35B	3.7%	40.2%
PAR	$455.55M	-18.5%	-10.2%
CTLP	$302.55M	21.3%	25.7%

Comparing DIEBOLD NIXDORF against the 4 most active filers in the same SIC group.

Cells marked with a small ◇ are sourced from SEC's bulk Financial Statement Data Sets, which can lose dimensional context (notably Revenue and Operating Income for issuers that report by segment). These cells will be replaced with authoritative values from the Company Facts API as the backfill completes.